-
Mashup Score: 10
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of menopause.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37The fetal origins of mental illness - 3 month(s) ago
The impact of infections and inflammation during pregnancy on the developing fetal brain remains incompletely defined, with important clinical and research gaps. Although the classic infectious TORCH pathogens (ie, Toxoplasma gondii, rubella virus, cytomegalovirus [CMV], herpes simplex virus) are known to be directly teratogenic, emerging evidence suggests that these infections represent the most extreme end of a much larger spectrum of injury. We present the accumulating evidence that prenatal exposure to a wide variety of viral and bacterial infections—or simply inflammation—may subtly alter fetal brain development, leading to neuropsychiatric consequences for the child later in life.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Hypertensive disorders of pregnancy and the risk of maternal dementia: a systematic review and meta-analysis - 3 month(s) ago
Hypertensive disorders of pregnancy, including preeclampsia, are associated with an increased risk for maternal cardiovascular disease, stroke, and chronic kidney disease. However, their association with subsequent maternal dementia or cognitive impairment is less well understood. This study aimed to review and synthesize the published literature on hypertensive disorders of pregnancy and the subsequent risk for maternal dementia or cognitive impairment.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Society for Maternal-Fetal Medicine Position Statement: Paid family and medical leave - 4 month(s) ago
Position: The Society for Maternal-Fetal Medicine strongly supports paid family leave and medical leave to optimize the health of pregnant people and their families and to improve health equity. All types of leave should include full wages and benefits and job protection to ensure that parents can care for themselves and their children. The Society for Maternal-Fetal Medicine endorses the implementation of a national policy that would provide fully-paid sick leave in addition to a minimum of 12 weeks of universal paid family and medical leave with job protection to optimize health and well-being across generations.
Source: www.ajog.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 58Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance - 5 month(s) ago
Qualitative and quantitative measurement of urine protein excretion is one of the most common tests performed during pregnancy. For more than 100 years, proteinuria was necessary for the diagnosis of preeclampsia, but recent guidelines recommend that proteinuria is sufficient but not necessary for the diagnosis. Still, in clinical practice, most patients with gestational hypertension will be diagnosed as having preeclampsia based on the presence of proteinuria. Although the reference standard for measuring urinary protein excretion is a 24-hour urine collection, spot urine protein-to-creatinine ratio is a reasonable “rule-out” test for proteinuria.
Source: www.ajog.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Social determinants of health and obstetric outcomes: A report and recommendations of the workshop of the Society for Maternal-Fetal Medicine - 6 month(s) ago
This article is a report of a 2-day workshop, entitled “Social determinants of health and obstetric outcomes,” held during the Society for Maternal-Fetal Medicine 2022 Annual Pregnancy Meeting. Participants’ fields of expertise included obstetrics, pediatrics, epidemiology, health services, health equity, community-based research, and systems biology. The Commonwealth Foundation and the Alliance of Innovation on Maternal Health cosponsored the workshop and the Society for Women’s Health Research provided additional support.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2The active phase of labor - 6 month(s) ago
The active phase of labor begins at various degrees of dilatation when the rate of dilatation transitions from the relatively flat slope of the latent phase to a more rapid slope. No diagnostic manifestations demarcate its onset, other than accelerating dilatation. It ends with apparent slowing of dilatation, a deceleration phase, which is usually short in duration and frequently undetected. Several aberrant labor patterns can be detected during the active phase, including protracted dilatation, arrest of dilatation, prolonged deceleration phase and failure of descent.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Obstetric violence is a misnomer - 7 month(s) ago
The term “obstetric violence” has been used in the legislative language of several countries to protect mothers from abuse during pregnancy. Subsequently, it has been expanded to include a spectrum of obstetric procedures, such as induction of labor, episiotomy, and cesarean delivery, and has surfaced in the peer-reviewed literature. The term “obstetric violence” can be seen as quite strong and emotionally charged, which may lead to misunderstandings or misconceptions. It might be interpreted as implying a deliberate act of violence by healthcare providers when mistreatment can sometimes result from systemic issues, lack of training, or misunderstandings rather than intentional violence.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Randomized controlled trials: not always the “gold standard” for evidence in obstetrics and gynecology - 7 month(s) ago
Randomized controlled trials are considered the “gold standard” for therapeutic interventions, and it is not uncommon for sweeping changes in medical practice to follow positive results from such trials. However, randomized controlled trials are not without their limitations. Physicians frequently view randomized controlled trials as infallible, whereas they tend to dismiss evidence derived from sources other than randomized controlled trials as less credible or reliable. In several situations in obstetrics and gynecology, there are no randomized controlled trials to help guide the clinician.
Source: www.ajog.orgCategories: General Medicine News, Hem/OncsTweet
RT @drteplinsky: https://t.co/ZL3er5vikV More reassuring data on safety of vaginal estrogen - meta analysis shows no increase in risk of #…